These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 34721381)
21. Expression of NKG2D ligands is downregulated by β-catenin signalling and associates with HCC aggressiveness. Cadoux M; Caruso S; Pham S; Gougelet A; Pophillat C; Riou R; Loesch R; Colnot S; Nguyen CT; Calderaro J; Celton-Morizur S; Guerra N; Zucman-Rossi J; Desdouets C; Couty JP J Hepatol; 2021 Jun; 74(6):1386-1397. PubMed ID: 33484773 [TBL] [Abstract][Full Text] [Related]
22. Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ. Galitska G; Coscia A; Forni D; Steinbrueck L; De Meo S; Biolatti M; De Andrea M; Cagliani R; Leone A; Bertino E; Schulz T; Santoni A; Landolfo S; Sironi M; Cerboni C; Dell'Oste V Front Immunol; 2021; 12():532484. PubMed ID: 33897679 [TBL] [Abstract][Full Text] [Related]
24. Hypothesis: Is there a link between the immune response to Human Herpes Virus type 6Α (HHV-6Α) infection and the interaction network (interactome) of the genes encoding the CTSS, PTX3, CHI3L1, Mx1, CXCL16, BIRC3 and BST2 proteins? Rouka E Med Hypotheses; 2018 Mar; 112():47-50. PubMed ID: 29447938 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of interleukin-2 gene expression by human herpesvirus 6B U54 tegument protein. Iampietro M; Morissette G; Gravel A; Flamand L J Virol; 2014 Nov; 88(21):12452-63. PubMed ID: 25122797 [TBL] [Abstract][Full Text] [Related]
26. Characterization of the human herpesvirus 6A U23 gene. Hayashi M; Yoshida K; Tang H; Sadaoka T; Kawabata A; Jasirwan C; Mori Y Virology; 2014 Feb; 450-451():98-105. PubMed ID: 24503071 [TBL] [Abstract][Full Text] [Related]
27. Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells. Hedlund M; Nagaeva O; Kargl D; Baranov V; Mincheva-Nilsson L PLoS One; 2011 Feb; 6(2):e16899. PubMed ID: 21364924 [TBL] [Abstract][Full Text] [Related]
28. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells. Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914 [TBL] [Abstract][Full Text] [Related]
30. [Matrine enhances the cytotoxic sensitivity of ABCG2high nasopharyngeal carcinoma cells to natural killer cells by inducing high expression of NKG2D receptor ligands]. Huang YX; Wang Y; Sun M; Zhou XY; Deng L; Guo KY Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1329-32. PubMed ID: 19620045 [TBL] [Abstract][Full Text] [Related]
31. Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ? Giuliani E; Vassena L; Cerboni C; Doria M Curr Drug Targets; 2016; 17(1):54-64. PubMed ID: 26122035 [TBL] [Abstract][Full Text] [Related]
32. A Murine Herpesvirus Closely Related to Ubiquitous Human Herpesviruses Causes T-Cell Depletion. Patel SJ; Zhao G; Penna VR; Park E; Lauron EJ; Harvey IB; Beatty WL; Plougastel-Douglas B; Poursine-Laurent J; Fremont DH; Wang D; Yokoyama WM J Virol; 2017 May; 91(9):. PubMed ID: 28179532 [TBL] [Abstract][Full Text] [Related]
33. Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma. Raffaghello L; Prigione I; Airoldi I; Camoriano M; Levreri I; Gambini C; Pende D; Steinle A; Ferrone S; Pistoia V Neoplasia; 2004; 6(5):558-68. PubMed ID: 15548365 [TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical validation and expression profiling of NKG2D ligands in a wide spectrum of human epithelial neoplasms. Fujita H; Hatanaka Y; Sutoh Y; Suzuki Y; Oba K; Hatanaka KC; Mitsuhashi T; Otsuka N; Fugo K; Kasahara M; Matsuno Y J Histochem Cytochem; 2015 Mar; 63(3):217-27. PubMed ID: 25473094 [TBL] [Abstract][Full Text] [Related]
35. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. Welte SA; Sinzger C; Lutz SZ; Singh-Jasuja H; Sampaio KL; Eknigk U; Rammensee HG; Steinle A Eur J Immunol; 2003 Jan; 33(1):194-203. PubMed ID: 12594848 [TBL] [Abstract][Full Text] [Related]
36. Clinical Impact of Natural Killer Group 2D Receptor Expression and That of Its Ligand in Ovarian Carcinomas: A Retrospective Study. Lee GH; An HJ; Kim TH; Kim G; Park KS; Park H; Lee TH; Kwon AY Yonsei Med J; 2021 Apr; 62(4):288-297. PubMed ID: 33779082 [TBL] [Abstract][Full Text] [Related]
37. The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB. Schmiedel D; Tai J; Yamin R; Berhani O; Bauman Y; Mandelboim O Elife; 2016 Mar; 5():. PubMed ID: 26982091 [TBL] [Abstract][Full Text] [Related]
38. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications. Chitadze G; Bhat J; Lettau M; Janssen O; Kabelitz D Scand J Immunol; 2013 Aug; 78(2):120-9. PubMed ID: 23679194 [TBL] [Abstract][Full Text] [Related]
39. [Expression and abscission of activated receptors and their ligands on/from NK cells in peripheral blood of patients with acute leukemia]. Fang XC; Liu HL; Sun ZM; Gui L; Geng LQ; Wang XB; Zhou M; Wang ZY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):436-40. PubMed ID: 20416183 [TBL] [Abstract][Full Text] [Related]